taxonomy (1)
protein (1)
source (2)
structure (0)
composition (21)
disease (1)
reference (3)
site (11)
peptide (10)
- Homo sapiens (Human)
Taxonomy
Reported structure
- Hex:1 HexNAc:1 (avg mass : 383.3527 )
- Hex:2 HexNAc:2 NeuAc:2 (avg mass : 1331.2059 )
- Hex:2 HexNAc:2 dHex:2 NeuAc:1 (avg mass : 1332.234 )
- Hex:5 HexNAc:3 NeuAc:1 (avg mass : 1729.5702 )
- Hex:5 HexNAc:4 NeuAc:1 (avg mass : 1932.7652 )
- Hex:5 HexNAc:4 NeuAc:2 (avg mass : 2224.0231 )
- Hex:5 HexNAc:4 dHex:1 NeuAc:1 (avg mass : 2078.9082 )
- Hex:5 HexNAc:4 dHex:1 NeuAc:2 (avg mass : 2370.1661 )
- Hex:5 HexNAc:4 dHex:2 NeuAc:1 (avg mass : 2225.0512 )
- Hex:5 HexNAc:4 dHex:2 NeuAc:2 (avg mass : 2516.3091 )
- Hex:6 HexNAc:4 NeuAc:2 (avg mass : 2386.1655 )
- Hex:6 HexNAc:5 NeuAc:2 (avg mass : 2589.3605 )
- Hex:6 HexNAc:5 NeuAc:3 (avg mass : 2880.6184 )
- Hex:6 HexNAc:5 dHex:2 NeuAc:1 (avg mass : 2590.3886 )
- Hex:6 HexNAc:5 dHex:2 NeuAc:2 (avg mass : 2881.6465 )
- Hex:6 HexNAc:5 dHex:3 NeuAc:2
- Hex:6 HexNAc:6 dHex:1 NeuAc:2 (avg mass : 2938.6985 )
- Hex:6 HexNAc:6 dHex:2 NeuAc:2
- Hex:6 HexNAc:6 dHex:2 NeuAc:3
- Hex:7 HexNAc:6 dHex:1 NeuAc:2 (avg mass : 3100.8409 )
- Hex:7 HexNAc:6 dHex:2 NeuAc:2
Composition
- Prostate cancer (DOID:10283)
Disease
- Large-scale intact glycopeptide identification by Mascot database search (2018 - Ravi Chand Bollineni, Christian Jeffrey Koehler, Randi Elin Gislefoss, Jan Haug Anonsen, Bernd Thiede) / Status : Unreviewed
- Distinct urinary glycoprotein signatures in prostate cancer patients (2018 - Rebeca Kawahara, Fabio Ortega, Livia Rosa-Fernandes, Vanessa Guimarães, Daniel Quina, Willian Nahas, Veit Schwämmle, Miguel Srougi, Katia R.M. Leite, Morten Thaysen-Andersen, Martin R. Larsen and Giuseppe Palmisano) / Status : Unreviewed
- Human urinary glycoproteomics; attachment site specific analysis of N- and O-linked glycosylations by CID and ECD (2012 - Halim A, Nilsson J, Rüetschi U, Hesse C, Larson G) / Status : Reviewed
Reference
- Protein heg homolog 1 / Homo sapiens
Reported glycosite
-
- Hex:1 HexNAc:1 / O-Linked (avg mass : 383.3527)
- Urine (UBERON_0001088)
- Protein heg homolog 1 / Homo sapiens
-
- Hex:2 HexNAc:2 NeuAc:2 / O-Linked (avg mass : 1331.2059)
- Urine (UBERON_0001088)
- Prostate cancer (DOID:10283)
- Protein heg homolog 1 / Homo sapiens
- APEPGAATQR (10aa)
-
- Hex:2 HexNAc:2 dHex:2 NeuAc:1 / O-Linked (avg mass : 1332.234)
- Urine (UBERON_0001088)
- Prostate cancer (DOID:10283)
- Protein heg homolog 1 / Homo sapiens
- APEPGAATQR (10aa)
-
- Hex:5 HexNAc:3 NeuAc:1 / N-Linked (avg mass : 1729.5702)
- Blood Serum (UBERON_0001977)
- Prostate cancer (DOID:10283)
- Protein heg homolog 1 / Homo sapiens
- TLNMCFSALPSYIR (14aa)
-
- Hex:5 HexNAc:4 NeuAc:1 / N-Linked (avg mass : 1932.7652)
- Blood Serum (UBERON_0001977)
- Prostate cancer (DOID:10283)
- Protein heg homolog 1 / Homo sapiens
- LNNSTGLQSSSVSQTK (16aa)
-
- Hex:5 HexNAc:4 dHex:1 NeuAc:1 / N-Linked (avg mass : 2078.9082)
- Blood Serum (UBERON_0001977)
- Prostate cancer (DOID:10283)
- Protein heg homolog 1 / Homo sapiens
- TLNMCFSALPSYIR (14aa)
-
- Hex:5 HexNAc:4 NeuAc:2 / N-Linked (avg mass : 2224.0231)
- Blood Serum (UBERON_0001977)
- Prostate cancer (DOID:10283)
- Protein heg homolog 1 / Homo sapiens
- LNNSTGLQSSSVSQTK (16aa)
- TFLNTTVEK (9aa)
- EAIEMHENGSTK (12aa)
-
- Hex:5 HexNAc:4 dHex:2 NeuAc:1 / N-Linked (avg mass : 2225.0512)
- Blood Serum (UBERON_0001977)
- Prostate cancer (DOID:10283)
- Protein heg homolog 1 / Homo sapiens
- TFLNTTVEK (9aa)
-
- Hex:5 HexNAc:4 dHex:1 NeuAc:2 / N-Linked (avg mass : 2370.1661)
- Blood Serum (UBERON_0001977)
- Prostate cancer (DOID:10283)
- Protein heg homolog 1 / Homo sapiens
- SHAASDAPENLTLLAETADAR (21aa)
- TFLNTTVEK (9aa)
- TLNMCFSALPSYIR (14aa)
- ESNAVVISLQTTFSLASNVTLFDLADR (27aa)
-
- Hex:6 HexNAc:4 NeuAc:2 / N-Linked (avg mass : 2386.1655)
- Blood Serum (UBERON_0001977)
- Prostate cancer (DOID:10283)
- Protein heg homolog 1 / Homo sapiens
- TLNMCFSALPSYIR (14aa)
-
- Hex:5 HexNAc:4 dHex:2 NeuAc:2 / N-Linked (avg mass : 2516.3091)
- Blood Serum (UBERON_0001977)
- Prostate cancer (DOID:10283)
- Protein heg homolog 1 / Homo sapiens
- ISNSSHSEYSSFFHAQTER (19aa)
- TFLNTTVEK (9aa)
-
- Hex:6 HexNAc:5 NeuAc:2 / N-Linked (avg mass : 2589.3605)
- Blood Serum (UBERON_0001977)
- Prostate cancer (DOID:10283)
- Protein heg homolog 1 / Homo sapiens
- TLNMCFSALPSYIR (14aa)
-
- Hex:6 HexNAc:5 dHex:2 NeuAc:1 / N-Linked (avg mass : 2590.3886)
- Blood Serum (UBERON_0001977)
- Prostate cancer (DOID:10283)
- Protein heg homolog 1 / Homo sapiens
- ALLSITDNSSSSDIVESSTSYIK (23aa)
-
- Hex:6 HexNAc:5 NeuAc:3 / N-Linked (avg mass : 2880.6184)
- Blood Serum (UBERON_0001977)
- Prostate cancer (DOID:10283)
- Protein heg homolog 1 / Homo sapiens
- ISNSSHSEYSSFFHAQTER (19aa)
-
- Hex:6 HexNAc:5 dHex:2 NeuAc:2 / N-Linked (avg mass : 2881.6465)
- Blood Serum (UBERON_0001977)
- Prostate cancer (DOID:10283)
- Protein heg homolog 1 / Homo sapiens
- TLNMCFSALPSYIR (14aa)
-
- Hex:6 HexNAc:5 dHex:3 NeuAc:2 / N-Linked
- Blood Serum (UBERON_0001977)
- Prostate cancer (DOID:10283)
- Protein heg homolog 1 / Homo sapiens
- NSSGPDLSWLHFYR (14aa)
- TLNMCFSALPSYIR (14aa)
-
- Hex:6 HexNAc:6 dHex:1 NeuAc:2 / N-Linked (avg mass : 2938.6985)
- Blood Serum (UBERON_0001977)
- Prostate cancer (DOID:10283)
- Protein heg homolog 1 / Homo sapiens
- TLNMCFSALPSYIR (14aa)
-
- Hex:6 HexNAc:6 dHex:2 NeuAc:2 / N-Linked
- Blood Serum (UBERON_0001977)
- Prostate cancer (DOID:10283)
- Protein heg homolog 1 / Homo sapiens
- TLNMCFSALPSYIR (14aa)
-
- Hex:6 HexNAc:6 dHex:2 NeuAc:3 / N-Linked
- Blood Serum (UBERON_0001977)
- Prostate cancer (DOID:10283)
- Protein heg homolog 1 / Homo sapiens
- TLNMCFSALPSYIR (14aa)
-
- Hex:7 HexNAc:6 dHex:1 NeuAc:2 / N-Linked (avg mass : 3100.8409)
- Blood Serum (UBERON_0001977)
- Prostate cancer (DOID:10283)
- Protein heg homolog 1 / Homo sapiens
- NSSGPDLSWLHFYR (14aa)
-
- Hex:7 HexNAc:6 dHex:2 NeuAc:2 / N-Linked
- Blood Serum (UBERON_0001977)
- Prostate cancer (DOID:10283)
- Protein heg homolog 1 / Homo sapiens
- TLNMCFSALPSYIR (14aa)
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
